Cargando…
Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone
[Image: see text] Despite the rapid evolution of therapeutic antibodies, their clinical efficacy in the treatment of bone tumors is hampered due to the inadequate pharmacokinetics and poor bone tissue accessibility of these large macromolecules. Here, we show that engineering therapeutic antibodies...
Autores principales: | Tian, Zeru, Yu, Chenfei, Zhang, Weijie, Wu, Kuan-Lin, Wang, Chenhang, Gupta, Ruchi, Xu, Zhan, Wu, Ling, Chen, Yuda, Zhang, Xiang H.-F., Xiao, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961797/ https://www.ncbi.nlm.nih.gov/pubmed/35355817 http://dx.doi.org/10.1021/acscentsci.1c01024 |
Ejemplares similares
-
Harnessing the power of antibodies to fight bone metastasis
por: Tian, Zeru, et al.
Publicado: (2021) -
Synthesis of precision antibody conjugates using proximity-induced chemistry
por: Cao, Yu J., et al.
Publicado: (2021) -
Prominin 1 Significantly Correlated with Bone Metastasis of Breast Cancer and Influenced the Patient's Prognosis
por: Yu, Cheng-cheng, et al.
Publicado: (2022) -
Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis
por: Zhu, Mingyu, et al.
Publicado: (2019) -
Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis
por: Li, Yixuan, et al.
Publicado: (2022)